Eclectic Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
AIM
MSV
VWM
SIS
QPBE
FFA
RT
WF
AAA
ACM
Eclectic Associates's PFE Position: Q3 2026 in Review
Eclectic Associates opened a new position in Pfizer (PFE) in Q3 2026: 7,535 shares worth $215K. The stake represents 0.02% of the portfolio and ranks #149 among its holdings. This is a return to the name: Eclectic Associates previously reported a position in PFE as recently as Q1 2026.
Eclectic Associates first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.57M in Q4 2021. 156 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Eclectic Associates held 7,535 shares of Pfizer worth $215K as of Q3 2026.
- Pfizer was a new Eclectic Associates position in Q3 2026.
- Pfizer made up 0.02% of Eclectic Associates's portfolio in Q3 2026, its #149 holding.
- Eclectic Associates first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
- Eclectic Associates's Pfizer position peaked at $1.57M in Q4 2021.
- 156 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Eclectic Associates's 13F filing for Q3 2026, filed 9 Oct 2026.